Table 1 Person demographics and illness characteristics at baseline
Person Characteristics | SfW N = 314 | Control N = 59 | P-Values |
|---|---|---|---|
Female patients, n (%) | 180 (57.3) | 30 (50.8) | 0.3574 |
Agea, yrs, (± SD) | 41.2 (± 11.97) | 39.9 (± 12.55) | 0.4532 |
Weighta, kg, (± SD) | 93.5 (± 20.88) | 87.6 (± 18.53) | 0.0437* |
Heighta, cm, (± SD) | 171.6 (± 9.43) | 171.8 (± 9.35) | 0.8765 |
BMIa, kg/m2, (± SD) | 31.7 (± 6.48) | 29.6 (± 5.33) | 0.0173* |
Waist circumferencea, cm, (± SD) | 107.5(± 18.52) | 105.9 (± 18.90) | 0.5544 |
Waist circumference Sensitivity analysisa, cm (± SD) | 106.4 (± 16.37) | 103.5(± 13.89) | 0.2115 |
15D total score a, (± SD) | 0.814 (± 0.12) | 0.857(± 0.09) | 0.0085* |
SWN total score a, (± SD) | 80.5 (± 15.97 | 87.9 (± 18.35) | 0.0016* |
Clinical Characteristics | |||
Psychiatric Diagnosis | 0.0627 | ||
Schizophrenia n (%) | 163 (51.9) | 40 (67.8) | |
Bipolar Disorder n (%) | 28 (8.9) | 5 (8.5) | |
Other n (%) | 123 (39.2) | 14 (23.7) | |
Time since diagnosisa, b, yrs, (± SD) | 9.47 (9.68) | 11.36 (12.27) | 0.1911 |
CGI-S total scorea, (± SD) | 4.1 (± 0.99) | 3.4 (± 1.59) | < 0.0001 |
Psychotropic medication | |||
Atypical antipsychotics n (%) c | 203 (64.6) | 46 (78.0) | |
Antidepressants n (%) | 124 (39.5) | 12 (20.3) | |
Typical Antipsychotics n (%) | 70 (22.3) | 14 (23.7) | |